These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30131168)

  • 81. Meeting pragmatism halfway: making a pragmatic clinical trial protocol.
    Rushforth A
    Sociol Health Illn; 2015 Nov; 37(8):1285-98. PubMed ID: 26235211
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Willingness to participate in pragmatic dialysis trials: the importance of physician decisional autonomy and consent approach.
    Courtright KR; Halpern SD; Joffe S; Ellenberg SS; Karlawish J; Madden V; Gabler NB; Szymanski S; Yadav KN; Dember LM
    Trials; 2017 Oct; 18(1):474. PubMed ID: 29020994
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Formulary restrictions may impact enrollment in pragmatic trials and limit generalizability of findings to vulnerable populations.
    Segal JB;
    Clin Trials; 2020 Dec; 17(6):729-731. PubMed ID: 32650667
    [No Abstract]   [Full Text] [Related]  

  • 84. Series: Pragmatic trials and real world evidence: Paper 4. Informed consent.
    Kalkman S; van Thiel GJMW; Zuidgeest MGP; Goetz I; Pfeiffer BM; Grobbee DE; van Delden JJM;
    J Clin Epidemiol; 2017 Sep; 89():181-187. PubMed ID: 28502809
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statement.
    Hohenschurz-Schmidt DJ; Cherkin D; Rice ASC; Dworkin RH; Turk DC; McDermott MP; Bair MJ; DeBar LL; Edwards RR; Farrar JT; Kerns RD; Markman JD; Rowbotham MC; Sherman KJ; Wasan AD; Cowan P; Desjardins P; Ferguson M; Freeman R; Gewandter JS; Gilron I; Grol-Prokopczyk H; Hertz SH; Iyengar S; Kamp C; Karp BI; Kleykamp BA; Loeser JD; Mackey S; Malamut R; McNicol E; Patel KV; Sandbrink F; Schmader K; Simon L; Steiner DJ; Veasley C; Vollert J
    Pain; 2023 Jul; 164(7):1457-1472. PubMed ID: 36943273
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Regulatory-grade clinical trial design using real-world data.
    Levenson MS
    Clin Trials; 2020 Aug; 17(4):377-382. PubMed ID: 32063037
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Importance of mixed methods in pragmatic trials and dissemination and implementation research.
    Albright K; Gechter K; Kempe A
    Acad Pediatr; 2013; 13(5):400-7. PubMed ID: 24011744
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Innovative and Pragmatic Research Designs Are Critical to Advance Nursing Science.
    Yates P
    Cancer Nurs; 2016; 39(3):251-2. PubMed ID: 27081921
    [No Abstract]   [Full Text] [Related]  

  • 89. [Progress in research of pragmatic-explanatory continuum indicator summary].
    Hu G; Hu Y; Zhan S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Mar; 37(3):439-42. PubMed ID: 27005554
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Series: Pragmatic trials and real world evidence: Paper 2. Setting, sites, and investigator selection.
    Worsley SD; Oude Rengerink K; Irving E; Lejeune S; Mol K; Collier S; Groenwold RHH; Enters-Weijnen C; Egger M; Rhodes T;
    J Clin Epidemiol; 2017 Aug; 88():14-20. PubMed ID: 28502811
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Will web surveys ever become part of mainstream research?
    Schonlau M
    J Med Internet Res; 2004 Sep; 6(3):e31. PubMed ID: 15471757
    [No Abstract]   [Full Text] [Related]  

  • 92. External validity: we need to do more.
    Glasgow RE; Green LW; Klesges LM; Abrams DB; Fisher EB; Goldstein MG; Hayman LL; Ockene JK; Orleans CT
    Ann Behav Med; 2006 Apr; 31(2):105-8. PubMed ID: 16542124
    [No Abstract]   [Full Text] [Related]  

  • 93. What does digitalization hold for the creation of real-world evidence?
    Pisaniello HL; Dixon WG
    Rheumatology (Oxford); 2020 Jan; 59(1):39-45. PubMed ID: 31834405
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Threats to internal validity in worksite health promotion program research: common problems and possible solutions.
    Conrad KM; Conrad KJ; Walcott-McQuigg J
    Am J Health Promot; 1991; 6(2):112-22. PubMed ID: 10148685
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems.
    Palmer JA; Mor V; Volandes AE; McCreedy E; Loomer L; Carter P; Dvorchak F; Mitchell SL
    Trials; 2018 Aug; 19(1):453. PubMed ID: 30134976
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Headache: Cluster headache treatment - RCTs versus real-world evidence.
    Martelletti P; Curto M
    Nat Rev Neurol; 2016 Oct; 12(10):557-8. PubMed ID: 27615424
    [No Abstract]   [Full Text] [Related]  

  • 97. Technomedia.
    Norrie P
    Nurse Res; 2007; 15(1):4-6. PubMed ID: 17992810
    [No Abstract]   [Full Text] [Related]  

  • 98. Applying the Plan-Do-Study-Act (PDSA) approach to a large pragmatic study involving safety net clinics.
    Coury J; Schneider JL; Rivelli JS; Petrik AF; Seibel E; D'Agostini B; Taplin SH; Green BB; Coronado GD
    BMC Health Serv Res; 2017 Jun; 17(1):411. PubMed ID: 28629348
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Barriers to the conduct of randomised clinical trials within all disease areas.
    Djurisic S; Rath A; Gaber S; Garattini S; Bertele V; Ngwabyt SN; Hivert V; Neugebauer EAM; Laville M; Hiesmayr M; Demotes-Mainard J; Kubiak C; Jakobsen JC; Gluud C
    Trials; 2017 Aug; 18(1):360. PubMed ID: 28764809
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Exploring the ethical and regulatory issues in pragmatic clinical trials.
    Califf RM; Sugarman J
    Clin Trials; 2015 Oct; 12(5):436-41. PubMed ID: 26374676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.